{
  "data": [
    {
      "variant": "DNA sequence affected",
      "assay_type": "Cell phenotype rescue assay",
      "evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The DNA sequence affected is likely pathogenic, as demonstrated by a cell phenotype rescue assay that employs both wild-type and mutant controls, uses multiple replicates, and reports statistically significant results with an OddsPath of > 18.7.",
      "evidence_evaluation": [
        {
          "step": "Define the disease mechanism",
          "extracted_info": "The paper clearly defines the molecular basis of the disease, with the affected gene (DNA sequence) being directly involved in the disease process by encoding a protein critical for cellular function.",
          "judgment": true
        },
        {
          "step": "Evaluate applicability of general classes of assay",
          "extracted_info": "The cell phenotype rescue assay effectively models the disease pathogenesis/mechanism by assessing the ability of different versions of the protein (wild-type and mutant) to restore normal function in cells.",
          "judgment": true,
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step": "Evaluate validity of specific instances of assays",
          "sub_step": "Basic Controls and Replicates",
          "extracted_info": "The paper describes the use of both wild-type and mutant controls as well as multiple replicates for their experiments.",
          "judgment": true
        },
        {
          "step": "Evaluate validity of specific instances of assays",
          "sub_step": "Variant Controls",
          "extracted_info": "The paper uses known pathogenic and benign variants as controls for the assay related to this variant.",
          "judgment": true
        },
        {
          "step": "Evaluate validity of specific instances of assays",
          "sub_step": "Statistical Analyses",
          "extracted_info": "The paper includes robust statistical analyses, including p-values and effect sizes, that allow for the estimation or calculation of OddsPath.",
          "judgment": true
        },
        {
          "step": "Apply evidence to individual variant interpretation",
          "sub_step": "Correlate OddsPath",
          "extracted_info": "The calculated OddsPath for this variant is > 18.7, indicating very high pathogenicity likelihood.",
          "judgment": true
        }
      ]
    },
    {
      "variant": "Protein-coding region affected",
      "assay_type": "Enzyme activity assay",
      "evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The protein-coding region affected is likely pathogenic, as demonstrated by an enzyme activity assay that uses both wild-type and mutant controls, includes multiple replicates, and reports statistically significant results with an OddsPath of > 2.0.",
      "evidence_evaluation": [
        {
          "step": "Define the disease mechanism",
          "extracted_info": "The paper clearly defines the molecular basis of the disease, with the affected protein playing a critical role in enzymatic function.",
          "judgment": true
        },
        {
          "step": "Evaluate applicability of general classes of assay",
          "extracted_info": "The enzyme activity assay effectively models the disease pathogenesis/mechanism by assessing the residual enzymatic activity of different versions of the protein (wild-type and mutant).",
          "judgment": true,
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step": "Evaluate validity of specific instances of assays",
          "sub_step": "Basic Controls and Replicates",
          "extracted_info": "The paper describes the use of both wild-type and mutant controls as well as multiple replicates for their experiments.",
          "judgment": true
        },
        {
          "step": "Evaluate validity of specific instances of assays",
          "sub_step": "Variant Controls",
          "extracted_info": "The paper does not explicitly mention the use of known pathogenic or benign variants as controls for the assay related to this variant.",
          "judgment": false
        },
        {
          "step": "Evaluate validity of specific instances of assays",
          "sub_step": "Statistical Analyses",
          "extracted_info": "The paper includes robust statistical analyses, including p-values and effect sizes, that allow for the estimation or calculation of OddsPath.",
          "judgment": true
        },
        {
          "step": "Apply evidence to individual variant interpretation",
          "sub_step": "Correlate OddsPath",
          "extracted_info": "The calculated OddsPath for this variant is > 2.0 and <= 4.3, indicating moderate pathogenicity likelihood.",
          "judgment": true
        }
      ]
    },
    {
      "variant": "mRNA splicing site affected",
      "assay_type": "Gene expression assay",
      "evidence_strength": {
        "type": "Pathogenic",
        "strength": "Max PS3_supporting"
      },
      "overall_conclusion": "The mRNA splicing site affected is likely pathogenic, as demonstrated by a gene expression assay that uses both wild-type and mutant controls, includes multiple replicates, and reports statistically significant results with an OddsPath not calculated but meets other criteria for Max PS3_supporting.",
      "evidence_evaluation": [
        {
          "step": "Define the disease mechanism",
          "extracted_info": "The paper clearly defines the molecular basis of the disease, with the affected mRNA splicing site playing a critical role in gene expression regulation and protein production.",
          "judgment": true
        },
        {
          "step": "Evaluate applicability of general classes of assay",
          "extracted_info": "The gene expression assay effectively models the disease pathogenesis/mechanism by assessing the impact of different versions of the mRNA (wild-type and mutant) on gene expression.",
          "judgment": true,
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step": "Evaluate validity of specific instances of assays",
          "sub_step": "Basic Controls and Replicates",
          "extracted_info": "The paper describes the use of both wild-type and mutant controls as well as multiple replicates for their experiments.",
          "judgment": true
        },
        {
          "step": "Evaluate validity of specific instances of assays",
          "sub_step": "Variant Controls",
          "extracted_info": "The paper does not explicitly mention the use of known pathogenic or benign variants as controls for the assay related to this variant.",
          "judgment": false
        },
        {
          "step": "Evaluate validity of specific instances of assays",
          "sub_step": "Statistical Analyses",
          "extracted_info": "The paper includes robust statistical analyses, including p-values and effect sizes, but does not calculate an OddsPath.",
          "judgment": true
        },
        {
          "step": "Apply evidence to individual variant interpretation",
          "sub_step": "Correlate OddsPath (not applicable)",
          "extracted_info": "",
          "judgment": false
        },
        {
          "step": "Apply evidence to individual variant interpretation",
          "sub_step": "Total Benign/Pathogenic Variant Controls",
          "extracted_info": "The paper uses at least 11 total benign and pathogenic variant controls across the entire study.",
          "judgment": true
        },
        {
          "step": "Apply evidence to individual variant interpretation",
          "sub_step": "OddsPath (not applicable)",
          "extracted_info": "",
          "judgment": false
        }
      ]
    }
  ]
}